tirzepatide better than retatrutide vs. Comparing the Big 3, Semaglutide,

Author reply 1775

Tirzepatide weight loss data (SURMOUNT trials) The SURMOUNT-1 trial changed the conversation about what was possible with pharmacological weight management

Current studies attribute the cardiovascular benefits of GLP-1 RA in reducing MACE predominantly to their anti-atherosclerotic properties [131]

Standard semaglutide The standard formulation contains only semaglutide as the active ingredient, with appropriate excipients for stability and sterility

Thus, GLP-1/FGF21 fusions have the potential, at least in rodents, to provide greater improvements in dyslipidemia than GLP-1R agonists and have the potential to drive greater body weight loss through the energy expenditure mechanism not evident with GLP-1 mono-therapy

As of May 1, 2024, there were 87 active lawsuits within the MDL, with potential growth to several thousand cases due to the drugs widespread usage